Infections à cytomégalovirus : Questions médicales fréquentes
Nom anglais: Cytomegalovirus Infections
Descriptor UI:D003586
Tree Number:C01.925.256.466.245
Termes MeSH sélectionnés :
Recovery of Function
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à cytomégalovirus : Questions médicales les plus fréquentes",
"headline": "Infections à cytomégalovirus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à cytomégalovirus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-20",
"dateModified": "2025-03-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à cytomégalovirus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à Herpesviridae",
"url": "https://questionsmedicales.fr/mesh/D006566",
"about": {
"@type": "MedicalCondition",
"name": "Infections à Herpesviridae",
"code": {
"@type": "MedicalCode",
"code": "D006566",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.256.466"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Infections à cytomégalovirus",
"alternateName": "Cytomegalovirus Infections",
"code": {
"@type": "MedicalCode",
"code": "D003586",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stipan Jonjić",
"url": "https://questionsmedicales.fr/author/Stipan%20Jonji%C4%87",
"affiliation": {
"@type": "Organization",
"name": "Department for Histology and Embryology and Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia. stipan.jonjic@medri.uniri.hr."
}
},
{
"@type": "Person",
"name": "Soren Gantt",
"url": "https://questionsmedicales.fr/author/Soren%20Gantt",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, 3175 Ch. de La Côte-Sainte-Catherine, Université de Montréal, Montréal, Canada."
}
},
{
"@type": "Person",
"name": "Shannon A Ross",
"url": "https://questionsmedicales.fr/author/Shannon%20A%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA."
}
},
{
"@type": "Person",
"name": "Christine M O'Connor",
"url": "https://questionsmedicales.fr/author/Christine%20M%20O%27Connor",
"affiliation": {
"@type": "Organization",
"name": "Genomic Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44016, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Application Effectiveness of Segment IV Portal Vein Reconstruction for Early Postoperative Liver Function Recovery in Split Liver Transplantation.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37181788",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/ti.2023.10808"
}
},
{
"@type": "ScholarlyArticle",
"name": "Super resolution imaging reconstruction reveals that gold standard methods may not correctly conclude neural/brain functional recovery.",
"datePublished": "2023-02-14",
"url": "https://questionsmedicales.fr/article/36805708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.compmedimag.2023.102198"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of a novel nested ensemble algorithm in predicting motor function recovery in patients with traumatic cervical spinal cord injury.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39075134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-65755-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Zinc regulates a specific subpopulation of VEGFA + microglia to improve the hypoxic microenvironment for functional recovery after spinal cord injury.",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37883817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2023.111092"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mesencephalic astrocyte-derived neurotrophic factor promotes axonal regeneration and the motor function recovery after sciatic nerve injury.",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37393642",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbrc.2023.06.056"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ADN",
"item": "https://questionsmedicales.fr/mesh/D004266"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections à Herpesviridae",
"item": "https://questionsmedicales.fr/mesh/D006566"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à cytomégalovirus",
"item": "https://questionsmedicales.fr/mesh/D003586"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à cytomégalovirus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à cytomégalovirus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à cytomégalovirus",
"description": "Comment diagnostique-t-on une infection à CMV ?\nQuels tests sont utilisés pour détecter le CMV ?\nLes symptômes aident-ils au diagnostic ?\nLe diagnostic est-il différent chez les nouveau-nés ?\nPeut-on diagnostiquer le CMV par imagerie ?",
"url": "https://questionsmedicales.fr/mesh/D003586?mesh_terms=Recovery+of+Function&page=8#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à cytomégalovirus",
"description": "Quels sont les symptômes courants d'une infection à CMV ?\nLes infections à CMV peuvent-elles être asymptomatiques ?\nQuels symptômes chez les immunodéprimés ?\nLe CMV peut-il affecter les yeux ?\nY a-t-il des symptômes spécifiques chez les nouveau-nés ?",
"url": "https://questionsmedicales.fr/mesh/D003586?mesh_terms=Recovery+of+Function&page=8#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à cytomégalovirus",
"description": "Comment prévenir les infections à CMV ?\nLes femmes enceintes doivent-elles se méfier du CMV ?\nLes vaccins contre le CMV existent-ils ?\nLe lavage des mains aide-t-il à prévenir le CMV ?\nLes personnes immunodéprimées doivent-elles être isolées ?",
"url": "https://questionsmedicales.fr/mesh/D003586?mesh_terms=Recovery+of+Function&page=8#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à cytomégalovirus",
"description": "Quels traitements sont disponibles pour le CMV ?\nLe traitement est-il nécessaire pour tous les patients ?\nY a-t-il des effets secondaires des traitements ?\nLe traitement préventif est-il possible ?\nCombien de temps dure le traitement du CMV ?",
"url": "https://questionsmedicales.fr/mesh/D003586?mesh_terms=Recovery+of+Function&page=8#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à cytomégalovirus",
"description": "Quelles sont les complications possibles du CMV ?\nLe CMV peut-il causer des problèmes de vision ?\nY a-t-il des complications chez les nouveau-nés ?\nLe CMV peut-il affecter le système nerveux ?\nLes complications sont-elles plus fréquentes chez les immunodéprimés ?",
"url": "https://questionsmedicales.fr/mesh/D003586?mesh_terms=Recovery+of+Function&page=8#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à cytomégalovirus",
"description": "Qui est le plus à risque d'infection à CMV ?\nLe contact avec des enfants augmente-t-il le risque ?\nLes personnes ayant reçu une greffe sont-elles à risque ?\nLe sexe influence-t-il le risque d'infection ?\nLes personnes vivant avec le VIH sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D003586?mesh_terms=Recovery+of+Function&page=8#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à CMV ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des cultures virales et des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter le CMV ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques, PCR et cultures cellulaires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter le diagnostic, mais des tests sont nécessaires."
}
},
{
"@type": "Question",
"name": "Le diagnostic est-il différent chez les nouveau-nés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diagnostic chez les nouveau-nés inclut des tests spécifiques comme l'audiométrie."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le CMV par imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut montrer des anomalies, mais le diagnostic nécessite des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection à CMV ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, fatigue, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections à CMV peuvent-elles être asymptomatiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes infectées par le CMV ne présentent aucun symptôme."
}
},
{
"@type": "Question",
"name": "Quels symptômes chez les immunodéprimés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chez les immunodéprimés, les symptômes peuvent inclure pneumonie, hépatite et rétinite."
}
},
{
"@type": "Question",
"name": "Le CMV peut-il affecter les yeux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le CMV peut provoquer une rétinite, entraînant des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les nouveau-nés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nouveau-nés peuvent présenter des symptômes comme des problèmes d'audition et des éruptions."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à CMV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'hygiène, l'évitement du contact avec les fluides corporels infectés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se méfier du CMV ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le CMV peut être transmis au fœtus, il est donc important de prendre des précautions."
}
},
{
"@type": "Question",
"name": "Les vaccins contre le CMV existent-ils ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre le CMV, mais des recherches sont en cours."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir le CMV ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains peut réduire le risque de transmission du CMV."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées doivent-elles être isolées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé d'isoler les personnes immunodéprimées des porteurs du CMV."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le CMV ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les antiviraux comme le ganciclovir et le foscarnet."
}
},
{
"@type": "Question",
"name": "Le traitement est-il nécessaire pour tous les patients ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le traitement est souvent réservé aux cas graves ou aux personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antiviraux peuvent provoquer des effets secondaires comme des nausées et des neutropénies."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements préventifs peuvent être administrés aux patients à haut risque."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement du CMV ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle peut durer plusieurs semaines à plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du CMV ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie, hépatite, rétinite et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Le CMV peut-il causer des problèmes de vision ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le CMV peut entraîner une rétinite, provoquant des pertes de vision."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications chez les nouveau-nés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nouveau-nés peuvent souffrir de troubles auditifs et de retards de développement."
}
},
{
"@type": "Question",
"name": "Le CMV peut-il affecter le système nerveux ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le CMV peut provoquer des encéphalites et d'autres troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez les immunodéprimés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées sont à risque accru de complications graves liées au CMV."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'infection à CMV ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées, les nouveau-nés et les femmes enceintes sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Le contact avec des enfants augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec des enfants, qui excrètent souvent le virus, augmente le risque."
}
},
{
"@type": "Question",
"name": "Les personnes ayant reçu une greffe sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les receveurs de greffe sont particulièrement vulnérables aux infections à CMV."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le sexe n'influence pas significativement le risque d'infection à CMV."
}
},
{
"@type": "Question",
"name": "Les personnes vivant avec le VIH sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes vivant avec le VIH sont à risque accru d'infections à CMV."
}
}
]
}
]
}
The objective of this study was to investigate the significance of portal vein reconstruction in segment IV of the liver on early postoperative liver function recovery in split liver transplantation. ...
The status of cerebral perfusion and its restoration level play a vital role in the prognosis and clinical decision making of many neurosurgical diseases. As such, gold standard methods including CT, ...
Traumatic cervical spinal cord injury (TCSCI) often causes varying degrees of motor dysfunction, common assessed by the International Standards for Neurological Classification of Spinal Cord Injury (I...
Spinal cord injury (SCI) is a central nervous system injury that is primarily traumatic and manifests as autonomic dysfunction below the level of injury. Our previous studies have found that zinc ions...
We investigated the effect of zinc ions after spinal cord injury from the perspective of a hypoxic microenvironment, and elucidated the role of VEGF-A secreted by microglia for vascular regeneration a...
Zinc promotes functional recovery after spinal cord injury by regulating VEGF-A secretion from microglia. On the one hand, VEGF-A secreted by microglia promotes angiogenesis through the PI3K/AKT/Bcl-2...
Zinc promoted microglia secretion of VEGF-A, increased vascular endothelial cell proliferation and migration through the PI3K/AKT/Bcl-2 pathway, and inhibited microglia apoptosis....
Peripheral nerve injuries have common clinical problems that are often accompanied by sensory and motor dysfunction and failure of axonal regeneration. Although various therapeutic approaches have bee...
There is a risk of pelvic floor dysfunction (PFD) from baby delivery. Many clinical guidelines recommend pelvic floor muscle training (PFMT) as the conservative treatment for PFD because pelvic floor ...
The randomized controlled trial was projected to be conducted from November 2021 to March 2023. A total of 260 postpartum women would be recruited from the obstetrics departments of the study hospital...
This trial will demonstrate that pelvic floor-care is accessible to most women and clinical practice on PFD may change relevantly should this study find that Online PEFLOW approach is effective to imp...
ClinicalTrials.gov, NCT05218239....
Evidence suggests that Bacillus coagulans TBC169 can improve intestinal motility....
To investigate the effectiveness and safety of Bacillus coagulans TBC169 probiotics in promoting the recovery of intestinal function after gynecological laparoscopic surgery....
Patients who underwent laparoscopic surgeries due to gynecological diseases were randomly assigned to the high-dose, conventional-dose, and the placebo-control groups (1:1:1 ratio). The primary outcom...
Compared to the placebo-control group, shorter FFT values were observed in the conventional-dose (23.15 h vs. 29.10 h, P < 0.05) and high-dose (19.15 h vs. 29.10 h, P < 0.001) groups. Similar trends w...
Bacillus coagulans TBC169 probiotics can accelerate intestinal function recovery, and reduce postoperative adverse events in patients after gynecological laparoscopic surgery. The study protocol was r...
This study was conducted to investigate the underlying associations between urine macrophages polarization and renal function recovery after nephron-sparing surgery (NSS) in patients with renal cell c...
Sixty-two patients with unilateral RCC who underwent NSS in our departments were prospectively recorded and followed up for long-term renal function to assess the onset of acute kidney injury (AKI) an...
The cumulative incidence of postoperative AKI was 27.4% (17/62), and 47.0% (8/17) of those eventually developed to CKD during the follow-up. The mean urine M1/M2 ratio was 10.54 ± 8.13 in the AKI grou...
Urine macrophages polarization could predict renal function recovery after NSS in patients with RCC. The urine M1/M2 ratio might a potential biomarker of RIRI but needs to be further verified in clini...
Patients with a spinal cord injury (SCI) usually suffer lifelong disability as a result. Considering this, SCI treatment and pathology study are urgently needed. Metformin, a widely used hypoglycemic ...
The duration of rehabilitation therapy is one of the key elements for promoting post-stroke functional recovery. However, whether an individual's age affects the effectiveness of the duration of rehab...
This study aimed to investigate whether age has an influence on the relationship between the duration of rehabilitation therapy and post-stroke functional recovery....
This is a retrospective observational study....
Six convalescent inpatient rehabilitation hospitals in Japan....
The population of the study was represented by a total of 1186 participants with subacute stroke....
Participants were stratified into four groups according to their age (≤59, 60-69, 70-79, and ≥80 years). The data of minutes involved in performing rehabilitation therapy for participants during hospi...
The mean FIM gains in the ≤59 years, 60-69 years, 70-79 years, and the ≥80 years groups were 38.7 (18.8), 32.8 (18.0), 29.7 (16.6), and 25.4 (17.2), respectively. The results of the multivariate regre...
For patients with subacute stroke in rehabilitation hospitals, a higher duration of daily rehabilitation therapy was associated with better functional recovery in the 70-79 years group and ≥80 years g...
An increased duration of daily rehabilitation therapy may be helpful in older adults with stroke selected for intensive rehabilitation for improvement of basic daily functioning....